Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q3 2024 · 10-Q
Revenue$4.93M$4.93M+134.8% vs Q3 2023 Net Income-$14.08M-$14.08MN/M vs Q3 2023 EPS, diluted—
Operating Income-$14,475,000N/M Operating Cash Flowderived-$4,201,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,210,000N/M Margins · derivedOperating margin-293.4%+554.8 pt vs Q3 2023
Net margin-285.4%+542.8 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end